English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduTwo new studies by Cedars-Sinai investigators support using artificial intelligence (AI) to predict sudden cardiac arrest—a health emergency that in 90% of cases leads to death within minutes.
Tag: Paul Noble
New Cedars-Sinai Study Pinpoints Why Some Injured Kidneys Do Not Heal
Cedars-Sinai investigators have discovered why some injured kidneys heal while others develop scarring that can lead to kidney failure. Their findings, detailed in a paper published in the peer-reviewed journal Science, could lead to the development of noninvasive tests to detect kidney scarring and, eventually, new therapies to reverse the condition.
Association of American Physicians Taps Cedars-Sinai Leader as President-Elect
Physician-scientist Paul Noble, MD, chair of the Department of Medicine at Cedars-Sinai, was named president-elect of the Association of American Physicians (AAP) at the group’s annual meeting in Chicago on April 22.
Cedars-Sinai Named to Pulmonary Fibrosis Foundation Care Center Network
The Pulmonary Fibrosis Foundation has named Cedars-Sinai part of its Care Center Network, a group of medical centers that have demonstrated expertise in treating and supporting people with this deadly disease.
HER2 Pathways in Breast Cancer May Hold Key to Effective Treatment of Idiopathic Pulmonary Fibrosis
LOS ANGELES (Oct. 13, 2022) — FINDINGS A new study led by Cedars-Sinai investigators suggests HER2 signaling may be a key driver of fibroblast invasion and can serve as a target for therapeutic intervention in idiopathic pulmonary fibrosis. HER2 is…
International Leader in Autoimmune Research to Lead Cedars-Sinai Institute
Nunzio Bottini, MD, PhD, whose groundbreaking research focuses on the role of a group of proteins in the development of rheumatic diseases, has joined Cedars-Sinai as the inaugural director of the Kao Autoimmunity Institute.